Last reviewed · How we verify
GSK HIV vaccine 732462 — Competitive Intelligence Brief
phase 1
Biologic
Live · refreshed every 30 min
Target snapshot
GSK HIV vaccine 732462 (GSK HIV vaccine 732462) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GSK HIV vaccine 732462 TARGET | GSK HIV vaccine 732462 | GlaxoSmithKline | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GSK HIV vaccine 732462 CI watch — RSS
- GSK HIV vaccine 732462 CI watch — Atom
- GSK HIV vaccine 732462 CI watch — JSON
- GSK HIV vaccine 732462 alone — RSS
Cite this brief
Drug Landscape (2026). GSK HIV vaccine 732462 — Competitive Intelligence Brief. https://druglandscape.com/ci/gsk-hiv-vaccine-732462. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab